Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 8, 2022
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
[ Mon, Aug 08th 2022
] - WOPRAI
Fri, August 5, 2022
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
[ Fri, Aug 05th 2022
] - WOPRAI
Jason Gerberry Upgraded (TEVA) to Strong Buy and Increased Target to $13 on, Aug 5th, 2022
Jason Gerberry of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy and Increased Target from $10 to $13 on, Aug 5th, 2022.
Jason has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $10 on, Tuesday, August 2nd, 2022
- Ashwani Verma of "UBS" Initiated at Hold and Held Target at $10 on, Tuesday, June 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Jason
- David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
- Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022
